(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

POPTISELECT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

POPTISELECT

ST13

US500000079257091

Class

1, 42

Filing

79257091

Registration

6010253

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

49

Latest update

03/17/2025

Trademark type

Word

Nice classes

1, 42

Filing date

01/09/2019

Registration date

03/17/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/17/2020

Last transaction

03/17/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

27

Owner location

DE

Examiner

HUSSAIN, TASNEEM

Law office

O30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

CEVEC Pharmaceuticals GmbH

Representatives

Dyan M. House Baker & Mckenzie, LLP

Technical classification

Nice Classes

Class 1Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicalbiological and biochemical substancespreparations and reagents for scientific researchlaboratory researchindustrial and commercial purposesexcept chromatography chemicals and mediaexcept chemicals for use in separation and purification; chemicalbiological and biochemical substancespreparations and reagents for researching and characterizing diseases except chromatography chemicals and mediaexcept chemicals for use in separation and purification; chemicalbiological and biochemical substancespreparations and reagents for scientific and medical research and drug development except chromatography chemicals and mediaexcept chemicals for use in separation and purification; chemicalbiological and biochemical substancespreparations and reagents for manufacturing drugs and pharmaceuticalsexcept chromatography chemicals and mediaexcept chemicals for use in separation and purification; cultures of microorganismsproteinspolypeptidesnucleotidesnucleic acidsin particular plasmidseukaryotic cell lines and eukaryotic cellsin particular transfected and/or selected eukaryotic cell lines and eukaryotic cells for scientific researchlaboratory researchindustrial and commercial purposes; all of the foregoing other than for medical or veterinary purposes

Class 42

Scientific and industrial researchin particular in the fields of medicinepharmacymolecular biologybiotechnology and genetics; research and development of drugsdiagnostic and analytical preparationstherapy procedures and expression systems; scientific and technological research and development services and related consultancyin particular in the field of medicinepharmacymolecular biologybiotechnology and genetics; scientific research and development relating to the cultivationextractionoptimizationsynthesizing and modifying of eukaryotic cell lineseukaryotic cellsmicroorganismspolypeptidesproteinsnucleotidesnucleic acidsfor third partiesin particular for use in the field of medicinepharmacymolecular biologybiotechnology and genetics; scientific researchanalysis and development services relating to the breedingobtainingoptimizingsynthesizing and modifying eukaryotic cell lineseukaryotic cellsin particular transfected and selected eukaryotic cells and eukaryotic cell lines with a nucleic acidin particular a plasmidfor third partiesin particular for use in the field of medicinepharmacymolecular biologybiotechnology and genetics; scientific analysis and development of transfected eukaryotic cells and eukaryotic cell lines for third partiesin particular for use in the field of medicinepharmacymolecular biologybiotechnology and genetics; all afore mentioned services except services relating to capture and intermediate purification of proteins

Publications

History of USPTO decisions and trademark events.

49 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

03/17/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/18/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/09/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

08/09/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/09/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/09/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/09/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

08/09/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/19/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/21/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

08/21/2023

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

08/21/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/21/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/21/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/21/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

08/21/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/13/2021

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

07/13/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/13/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/13/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/11/2021

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

06/11/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/11/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/11/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/14/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/27/2020

FIMP

FINAL DISPOSITION PROCESSED

07/27/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/17/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

03/17/2020

GPNX

NOTIFICATION PROCESSED BY IB

01/04/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/31/2019

PUBO

PUBLISHED FOR OPPOSITION

12/31/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/18/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

12/18/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/11/2019

ALIE

ASSIGNED TO LIE

11/20/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/19/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/14/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/13/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/13/2019

RFNP

REFUSAL PROCESSED BY IB

06/14/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/25/2019

RFRR

REFUSAL PROCESSED BY MPU

05/25/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/30/2019

MAFR

APPLICATION FILING RECEIPT MAILED

04/30/2019

CNRT

NON-FINAL ACTION WRITTEN

04/29/2019

DOCK

ASSIGNED TO EXAMINER

04/26/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/26/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

04/25/2019

Continuous trademark protection

Get notified about every new filing that threatens POPTISELECT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.